HI HB139

Requires health insurers, mutual benefit societies, and health maintenance organizations to cover standard fertility preservation services for policyholders and covered individuals under age 26 who face iatrogenic infertility from cancer treatments

Defines "iatrogenic infertility" as fertility impairment caused by surgery, chemotherapy, radiation, or other medical treatments affecting reproductive organs or processes

Prohibits insurers from using prior diagnoses or fertility treatments to exclude coverage, and bans discrimination based on life expectancy, disability, or perceived quality of life

Excludes experimental procedures, third-party assisted reproduction (donor eggs, surrogates, gestational carriers), and cryopreservation storage from required coverage

Coverage requirements apply to policies issued or renewed after December 31, 2025, with the Act taking effect December 31, 2050